Neumeier Poma Investment Counsel LLC lifted its stake in shares of CBIZ, Inc. (NYSE:CBZ - Free Report) by 2.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 456,062 shares of the business services provider's stock after buying an additional 10,862 shares during the quarter. CBIZ makes up approximately 3.6% of Neumeier Poma Investment Counsel LLC's portfolio, making the stock its 6th biggest position. Neumeier Poma Investment Counsel LLC owned 0.91% of CBIZ worth $37,320,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Geneva Capital Management LLC raised its holdings in CBIZ by 49.7% during the fourth quarter. Geneva Capital Management LLC now owns 423,407 shares of the business services provider's stock worth $34,647,000 after purchasing an additional 140,493 shares in the last quarter. FMR LLC lifted its position in CBIZ by 27.4% during the 3rd quarter. FMR LLC now owns 594,660 shares of the business services provider's stock worth $40,015,000 after acquiring an additional 127,822 shares during the period. Barclays PLC increased its holdings in shares of CBIZ by 362.1% in the third quarter. Barclays PLC now owns 78,711 shares of the business services provider's stock valued at $5,298,000 after purchasing an additional 61,679 shares during the period. Artemis Investment Management LLP raised its stake in shares of CBIZ by 18.5% during the fourth quarter. Artemis Investment Management LLP now owns 393,910 shares of the business services provider's stock worth $32,234,000 after purchasing an additional 61,376 shares during the last quarter. Finally, Summit Creek Advisors LLC lifted its holdings in shares of CBIZ by 19.9% during the fourth quarter. Summit Creek Advisors LLC now owns 304,076 shares of the business services provider's stock worth $24,883,000 after purchasing an additional 50,435 shares during the period. Institutional investors and hedge funds own 87.44% of the company's stock.
CBIZ Price Performance
Shares of CBZ traded up $0.41 during trading hours on Monday, reaching $75.38. The company had a trading volume of 53,325 shares, compared to its average volume of 316,508. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.36. CBIZ, Inc. has a 12-month low of $62.66 and a 12-month high of $90.13. The firm has a 50 day simple moving average of $80.27 and a 200-day simple moving average of $76.84. The company has a market capitalization of $4.05 billion, a price-to-earnings ratio of 31.98 and a beta of 0.99.
Wall Street Analysts Forecast Growth
CBZ has been the topic of several analyst reports. William Blair reaffirmed an "outperform" rating on shares of CBIZ in a report on Thursday, February 27th. StockNews.com downgraded CBIZ from a "hold" rating to a "sell" rating in a research note on Tuesday, February 25th.
Check Out Our Latest Analysis on CBZ
Insider Activity at CBIZ
In other CBIZ news, Director Benaree Pratt Wiley sold 6,526 shares of the firm's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $71.75, for a total transaction of $468,240.50. Following the completion of the transaction, the director now directly owns 41,759 shares in the company, valued at approximately $2,996,208.25. This trade represents a 13.52 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 5.40% of the stock is currently owned by company insiders.
About CBIZ
(
Free Report)
CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.
Further Reading

Before you consider CBIZ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CBIZ wasn't on the list.
While CBIZ currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.